| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2019 | 45 | 54,418 | NEO, PODD, TWLO, CY | 13F-HR | 11/14/2019 | 000089271219000397 |
| Q2 2019 | 47 | 87,772 | NEO, TWLO, VCEL, CY | 13F-HR | 8/14/2019 | 000089271219000305 |
| Q1 2019 | 59 | 123,591 | TWLO, NEO, VCEL, UPLD | 13F-HR | 5/15/2019 | 000089271219000201 |
| Q4 2018 | 61 | 102,509 | VCEL, TWLO, IDTI, NEO | 13F-HR | 2/14/2019 | 000089271219000064 |
| Q3 2018 | 58 | 118,825 | NEO, TWLO, IDTI, VCEL | 13F-HR | 11/14/2018 | 000089271218000462 |
| Q2 2018 | 59 | 106,597 | XENT, NEO, LGND, IDTI | RESTATEMENT | 8/15/2018 | 000089271218000370 |
| Q1 2018 | 65 | 98,362 | XENT, SRGA, PODD, LGND | 13F-HR | 5/14/2018 | 000089271218000222 |
| Q4 2017 | 65 | 99,842 | XENT, OCLR, Callidus Software Inc., SRGA | 13F-HR | 2/14/2018 | 000089271218000102 |
| Q3 2017 | 65 | 109,119 | OCLR, XENT, TLGT, NEO | 13F-HR | 11/14/2017 | 000089271217000756 |
| Q2 2017 | 64 | 111,708 | OCLR, XENT, TLGT, SRGA | 13F-HR | 8/14/2017 | 000089271217000604 |
| Q1 2017 | 61 | 102,319 | OCLR, XENT, TLGT, FNSR | 13F-HR | 5/15/2017 | 000089271217000422 |
| Q4 2016 | 61 | 94,715 | OCLR, FNSR, XENT, TLGT | 13F-HR | 2/14/2017 | 000089271217000136 |
| Q3 2016 | 64 | 101,182 | OCLR, FNSR, TLGT, GIMO | 13F-HR | 11/14/2016 | 000089271216001998 |
| Q2 2016 | 62 | 188,012 | OCLR, TLGT, NEO, GIMO | 13F-HR | 8/15/2016 | 000089271216001826 |
| Q1 2016 | 66 | 183,334 | OCLR, FNSR, NEO, XENT | 13F-HR | 5/16/2016 | 000089271216001677 |
| Q4 2015 | 65 | 203,418 | OCLR, EMKR, TLGT, XENT | 13F-HR | 2/16/2016 | 000089271216001402 |
| Q3 2015 | 65 | 185,935 | OCLR, EMKR, IGI Laboratories, Inc., XENT | 13F-HR | 11/16/2015 | 000089271215000994 |
| Q2 2015 | 67 | 224,535 | OCLR, EMKR, FNSR, SUPN | 13F-HR | 8/14/2015 | 000089271215000782 |
| Q1 2015 | 73 | 225,963 | VTSS, FNSR, OCLR, EMKR | 13F-HR | 5/15/2015 | 000089271215000585 |
| Q4 2014 | 71 | 208,031 | VTSS, FNSR, OCLR, EMKR | 13F-HR | 2/13/2015 | 000089271215000225 |
| Q3 2014 | 68 | 202,109 | VTSS, EMKR, FNSR, OCLR | 13F-HR | 11/4/2014 | 000089271214000793 |
| Q2 2014 | 71 | 217,636 | OCLR, FNSR, VTSS, EMKR | 13F-HR | 8/1/2014 | 000089271214000561 |
| Q1 2014 | 67 | 238,467 | OCLR, FNSR, VTSS, EMKR | 13F-HR | 4/25/2014 | 000089271214000309 |
| Q4 2013 | 64 | 221,092 | FNSR, OCLR, EMKR, ALA | 13F-HR | 1/21/2014 | 000089271214000082 |